BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29526626)

  • 1. Serum concentrations of fatty acid-binding protein 4 in Chinese children with type 1 diabetes mellitus.
    Liu H; Guo M; Jiang FL
    J Diabetes Complications; 2018 May; 32(5):488-491. PubMed ID: 29526626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications.
    Chiarelli F; Spagnoli A; Basciani F; Tumini S; Mezzetti A; Cipollone F; Cuccurullo F; Morgese G; Verrotti A
    Diabet Med; 2000 Sep; 17(9):650-6. PubMed ID: 11051284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Family CHAOS is associated with glycaemic control in children and adolescents with type 1 diabetes mellitus.
    Chae M; Taylor BJ; Lawrence J; Healey D; Reith DM; Gray A; Wheeler BJ
    Acta Diabetol; 2016 Feb; 53(1):49-55. PubMed ID: 25820470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of deprivation on glycaemic control in youth with type 1 diabetes in the southwestern region of France.
    Delagrange M; Dalla-Vale F; Salet R; Asensio-Weiss V; Moulin P; Cabaret B; Colmel C; Morin C; Talvard M; LeTallec C
    Pediatr Diabetes; 2021 Aug; 22(5):796-806. PubMed ID: 33205845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metabolic control in children and adolescents with diabetes mellitus type I in Berne: a cross-sectional study].
    Flück CE; Kuhlmann BV; Mullis PE
    Schweiz Med Wochenschr; 1999 Nov; 129(44):1650-5. PubMed ID: 10588023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of periodontal disease for glycaemic control in people with diabetes mellitus.
    Simpson TC; Weldon JC; Worthington HV; Needleman I; Wild SH; Moles DR; Stevenson B; Furness S; Iheozor-Ejiofor Z
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD004714. PubMed ID: 26545069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of random blood glucose as a predictor of the quality of glycaemic control by glycated haemoglobin in out-patient diabetic patients at Kenyatta National Hospital.
    Otieno FC; Ng'ang'a L; Kariuki M
    East Afr Med J; 2002 Sep; 79(9):491-5. PubMed ID: 12625691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty acid-binding protein 4: a key regulator of ketoacidosis in new-onset type 1 diabetes.
    Gruber N; Rathaus M; Ron I; Livne R; Sheinvald S; Barhod E; Hemi R; Tirosh A; Pinhas-Hamiel O; Tirosh A
    Diabetologia; 2022 Feb; 65(2):366-374. PubMed ID: 34806114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sociodemographic determinants of glycaemic control among children with type 1 diabetes in South Eastern Nigeria.
    Ogugua CF; Chikani UN; Okiche CY; Ibekwe UM
    Pan Afr Med J; 2021; 38():250. PubMed ID: 34104298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycaemic control and its associated factors in Chinese adults with type 1 diabetes mellitus.
    Liu L; Yang D; Zhang Y; Lin S; Zheng X; Lin S; Chen L; Zhang X; Li L; Liang G; Yao B; Yan J; Weng J
    Diabetes Metab Res Rev; 2015 Nov; 31(8):803-10. PubMed ID: 26386354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter cross-sectional analysis of values of glycated haemoglobin (HbA1c) in Polish children and adolescents with long-term type 1 diabetes in Poland: PolPeDiab study group.
    Jarosz-Chobot P; Polańska J; Myśliwiec M; Szadkowska A; Fendler W; Kamińska H; Chumiecki M; Mianowska B; Techmańska I; Sztangierska B; Młynarski W;
    Pediatr Endocrinol Diabetes Metab; 2012; 18(4):125-9. PubMed ID: 23739615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Young people with Type 1 diabetes of non-white ethnicity and lower socio-economic status have poorer glycaemic control in England and Wales.
    Khanolkar AR; Amin R; Taylor-Robinson D; Viner RM; Warner JT; Stephenson T
    Diabet Med; 2016 Nov; 33(11):1508-1515. PubMed ID: 26802317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Osteopontin in the Pathogenesis and Complications of Type 1 Diabetes Mellitus in Children.
    Talat MA; Sherief LM; El-Saadany HF; Rass AA; Saleh RM; Sakr MM
    J Clin Res Pediatr Endocrinol; 2016 Dec; 8(4):399-404. PubMed ID: 27353561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HbA1c tracking and bio-psychosocial determinants of glycaemic control in children and adolescents with type 1 diabetes: retrospective cohort study and multilevel analysis.
    Lawes T; Franklin V; Farmer G
    Pediatr Diabetes; 2014 Aug; 15(5):372-83. PubMed ID: 24279611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic Ketoacidosis Severity at Diagnosis and Glycaemic Control in the First Year of Childhood Onset Type 1 Diabetes-A Longitudinal Cohort Study.
    Khanolkar AR; Amin R; Taylor-Robinson D; Viner RM; Warner J; Gevers EF; Stephenson T
    Int J Environ Res Public Health; 2017 Dec; 15(1):. PubMed ID: 29295580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor glycaemic control is associated with increased risk of neurodevelopmental disorders in childhood-onset type 1 diabetes: a population-based cohort study.
    Liu S; Kuja-Halkola R; Larsson H; Lichtenstein P; Ludvigsson JF; Svensson AM; Gudbjörnsdottir S; Tideman M; Serlachius E; Butwicka A
    Diabetologia; 2021 Apr; 64(4):767-777. PubMed ID: 33454829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycaemic control in type 1 diabetes mellitus among children and adolescents in a resource limited setting in Dar es Salaam - Tanzania.
    Noorani M; Ramaiya K; Manji K
    BMC Endocr Disord; 2016 May; 16(1):29. PubMed ID: 27246505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapy.
    Furuhashi M; Sakuma I; Morimoto T; Higashiura Y; Sakai A; Matsumoto M; Sakuma M; Shimabukuro M; Nomiyama T; Arasaki O; Node K; Ueda S
    Cardiovasc Diabetol; 2020 Jun; 19(1):89. PubMed ID: 32539832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal study of serum insulin-like growth factor-I levels over 6 years in a large cohort of children and adolescents with type 1 diabetes mellitus: A marker reflecting diabetic retinopathy.
    Öberg D; Salemyr J; Örtqvist E; Juul A; Bang P
    Pediatr Diabetes; 2018 Aug; 19(5):972-978. PubMed ID: 29663652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.